Korean startup Mirint’s laser solution relieves allergic rhinitis effects

Allergic rhinitis affects more than 500 million people globally, impairing the quality of life and well-being. Korean startup Mirint Co., Ltd CEO YongHo Kim got motivated to start the company as he could not find a reasonable solution for his allergies. Mirint has developed a patented portable laser treatment solution for allergy patients – KoRhina – that uses bioactive effects without any side effects. It also helps in prevention of recurring allergies.

Device also helps in the prevention

KoRhina was developed for rhinitis patients with allergies, and it can be carried around anywhere to treat the condition with convenience. Its laser expansion feature enables a wider area coverage for better treatment effect. The device has 63% effectiveness in reducing eosinophils (main effector cells in allergic rhinitis) over 30% effectiveness with normal laser. The small wearable medical device improves allergic rhinitis by irradiating 650nm and 5mW of semiconductor laser in the nasal cavity.

The device, worn directly on the nose, can be controlled with smartphones. With KoRhina, it is possible to see the personal health info through integrating the smartphone app. Also, the device provides environmental information that allergic people react to, like pollen, dust, weather, temperature and humidity so that the patients can take preventive actions. The main consumer group is rhinitis patients in their teens to 30s, but all age groups can use it.

View this post on Instagram

A post shared by 코라이나 (@korhina_mirint)

To launch device in the USA in 2022

Mirint Co., Ltd. was established in November 2014 and has been working with domestic and overseas global companies to help rhinitis patients. Mirint had introduced KoRhina in 2019 at the 11th MIK (Made in Korea) Conference & Networking Season I. Within three months of its official launch, the device had 1500 customers. The startup is working on enhancing the features of the medical device and add more functions. It is likely to introduce Enhanced Laser Diffusion functions by 2022. The startup’s revenue strategy is through device sales and subscription to the AI-driven platform.

The company’s team has experienced engineers and researchers and has an advisory network of medical and laser specialists. Mirint has been selected for the Tech Incubator Program for Start-up (TIPS)by Ministry of SMEs and Startups of Korea in July 2019. KoRhino has won awards for its design and innovation, including a grand prize at the 15th Digital Innovation Award 2020 by the Ministry of Science and ICT. Mirint plans to launch the device in the USA next year and then expand the business to China, Japan and European countries.

Also Read,